Literature DB >> 12154326

Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients.

Christopher B Stefanelli1, David J Bradley, Sarah Leroy, Macdonald Dick, Gerald A Serwer, Peter S Fischbach.   

Abstract

OBJECTIVES: This study examined the indications, efficacy and outcomes of implantable cardioverter defibrillator (ICD) use in the pediatric population.
BACKGROUND: ICDs are first-line therapy for adults resuscitated from sudden cardiac death (SCD) or at high risk for life-threatening ventricular arrhythmias. Use of ICDs in children and young adults is infrequent and there are few data regarding this group.
METHODS: We abstracted and analyzed data for all patients in whom ICDs were implanted.
RESULTS: A total of 38 devices were implanted in 27 patients. Age ranged from 6 to 26 years (mean, 14) and weight ranged from 16 to 124 kg (mean, 47). Diagnoses included long QT syndrome (9), hypertrophic cardiomyopathy [6], repaired congenital heart disease [5];, and idiopathic ventricular tachycardia/fibrillation [4]. Indications comprised resuscitated SCD [15], syncope [9], and life-threatening ventricular arrhythmia [3]. Initial device placement was infraclavicular in 13, abdominal in 13 and intrathoracic in 1. Epicardial leads were used with 5 systems. A single coil lead was used in 17. Seven patients, all previously resuscitated from SCD, experienced 88 appropriate successful discharges. There were 6 inappropriate discharges in 3 patients. Mean time to device replacement was 3.1 years (n = 11). Complications included 2 infected systems, 2 lead dislodgments, 2 lead fractures, 1 post-pericardiotomy syndrome, 1 adverse event with defibrillation threshold (DFT); testing, and 1 patient with psychiatric sequelae. No deaths occurred with implanted ICDs.
CONCLUSIONS: These data demonstrate that ICDs provide safe and effective therapy in young patients. The indications for ICDs as primary preventive therapy remain uncertain.

Entities:  

Mesh:

Year:  2002        PMID: 12154326     DOI: 10.1023/a:1019509803992

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  19 in total

1.  Placement of an automatic implantable cardioverter-defibrillator in a 6-month-old infant: anesthetic management.

Authors:  C Dumont; L Dumont; C Mardirosoff; A De Villé
Journal:  J Cardiothorac Vasc Anesth       Date:  2000-02       Impact factor: 2.628

2.  ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors:  G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

Review 3.  Implantable cardioverter-defibrillators in children. A perspective on current and future uses.

Authors:  M J Silka
Journal:  J Electrocardiol       Date:  1996       Impact factor: 1.438

4.  Automatic implantable cardioverter defibrillator implantation for malignant ventricular arrhythmias associated with congenital heart disease.

Authors:  M A Kral; H M Spotnitz; A Hordof; J T Bigger; J S Steinberg; F D Livelli
Journal:  Am J Cardiol       Date:  1989-01-01       Impact factor: 2.778

5.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

6.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors:  M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

7.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

8.  Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.

Authors:  M J Silka; J Kron; A Dunnigan; M Dick
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

9.  Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. The Medtronic Transvene Investigators.

Authors:  J Kron; M J Silka; O J Ohm; G Bardy; D Benditt
Journal:  Pacing Clin Electrophysiol       Date:  1994-01       Impact factor: 1.976

10.  Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.

Authors:  D P Zipes; D Roberts
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

View more
  12 in total

1.  Implantable cardioverter-defibrillators for children and young adolescents: mortality benefit confirmed--what's next?

Authors:  S F Sears; J B Conti
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

2.  Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients.

Authors:  Andrew E Radbill; John K Triedman; Charles I Berul; Edward P Walsh; Mark E Alexander; Gregory Webster; Frank Cecchin
Journal:  Pacing Clin Electrophysiol       Date:  2012-09-14       Impact factor: 1.976

Review 3.  Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.

Authors:  Jim T Vehmeijer; Tom F Brouwer; Jacqueline Limpens; Reinoud E Knops; Berto J Bouma; Barbara J M Mulder; Joris R de Groot
Journal:  Eur Heart J       Date:  2016-02-11       Impact factor: 29.983

4.  Implantable cardioverter defibrillator implantation in children in The Netherlands.

Authors:  A Derk Jan Ten Harkel; Nico A Blom; Annette G Reimer; Raymond Tukkie; Narayanswami Sreeram; Margreet T E Bink-Boelkens
Journal:  Eur J Pediatr       Date:  2005-04-21       Impact factor: 3.183

5.  Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease.

Authors:  Nicholas H Von Bergen; Dianne L Atkins; Macdonald Dick; David J Bradley; Susan P Etheridge; Elizabeth V Saarel; Peter S Fischbach; Seshadri Balaji; Narayanswami Sreeram; William N Evans; Ian H Law
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

6.  Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy.

Authors:  Brian Feingold; Gaurav Arora; Steven A Webber; Kenneth J Smith
Journal:  J Card Fail       Date:  2010-06-08       Impact factor: 5.712

7.  Health related quality of life and social support in pediatric patients with pacemakers.

Authors:  Patricia Cheng; Ana M Gutierrez-Colina; Kristin A Loiselle; Margaret Strieper; Patrick Frias; Kevin Gooden; Ronald L Blount
Journal:  J Clin Psychol Med Settings       Date:  2014-03

8.  Psychological functioning and disease-related quality of life in pediatric patients with an implantable cardioverter defibrillator.

Authors:  H M Koopman; C M J Vrijmoet-Wiersma; J N D Langius; F van den Heuvel; S A Clur; C A Blank; N A Blom; A D J ten Harkel
Journal:  Pediatr Cardiol       Date:  2012-04       Impact factor: 1.655

Review 9.  Optimal antiarrhythmic drug therapy for electrical storm.

Authors:  Dan Sorajja; Thomas M Munger; Win-Kuang Shen
Journal:  J Biomed Res       Date:  2015-01-15

10.  Successful treatment of cardiac electrical storm in dilated cardiomyopathy using esmolol: A case report.

Authors:  L I Li; Yuan-Li Zhou; Xue-Jing Zhang; Hua-Ting Wang
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.